|
|
| NIG-RNAi Strains Detail |
| Request : Click the "Order" button to request for this stock |
discarded
|
| Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
| Stock ID |
1090R-2 |
| Symbol |
CG1090 |
Full Name |
CG1090 |
| CG No |
CG1090 |
Old CG No |
CG1090 |
| Synonyms |
CG1090 |
| Accession No (Link to NCBI) |
NM_141202.2 |
| Inserted Chr. |
lll |
| Insertional Mutation |
|
| Phenotype induced by Act5C-GAL4 at 28 degrees |
viable |
| Map Viewer |
|
Reference
[Please submit your publication]
|
Dourlen P, Fernandez-Gomez FJ, Dupont C, Grenier-Boley B, Bellenguez C, Obriot H, Caillierez R, Sottejeau Y, Chapuis J, Bretteville A, Abdelfettah F, Delay C, Malmanche N, Soininen H, Hiltunen M, Galas MC, Amouyel P, Sergeant N, Buée L, Lambert JC, Dermaut B.
Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology.
Mol. Psychiatry (2017) 22(6) 874-883
[
PubMed ID = 27113998
]
[
RRC reference
]
|
| Comment |
|
| Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
| Primer Seq. 5' |
aaggcctacatggccggaccgCTCCGCCAAAGGAGACACCAA |
| Primer Seq. 3' |
aatctagaggtaccTGCCGATGTCGTCCTTAGCAA |
| Predicted Fragment Size |
500 |
| IR fragment full Seq |
0001 CTCCGCCAAA GGAGACACCA AGGACGGACA GGTCCTGCCT CTGGATGTGG GCGCTCTGGC
0061 CGAGGACGCT GGCGATGcCG AGGCCAACGG AGAGGATACT CCAGAGAGAA ACTCAGAGAG
0121 TTCCGTTCTG GACACAACAC TGGCGTTTGA GcCTCAGGCG AGTACACAAT CGACTCCCAT
0181 TCATGGCGCG GTTCCCACCT GGCGCCCAAA GCGGGACAAC TGCACGcCCC CGGCTATCGA
0241 GCAGTTTCCA CAGCCGCTGA TGAATAAGTG GGCGCGACAG cACGGCGGCC TTATCCTCCA
0301 CATACTGGTG GCAGTCTTCA CTTTCTTCGG GTTGGCAATA GTTTGCGATG AGTACTTTGT
0361 GGCCAGTCTG GATCGGCTTT GCGAGGAGCT AAAGCTATCG CCAGATGTTG CGGGAGCCAC
0421 GTTTATGGCT GCCGGAAGCT CGGCTCCTGA ACTGGCCACT GTGGTGATAG GAGTGTTCTT
0481 TGCTAAGGAC CACATCGGCA |
| in silico PCR Fragment |
0001 CTCCGCCAAA GGAGACACCA AGGACGGACA GGTCCTGCCT CTGGATGTGG GCGCTCTGGC
0061 CGAGGACGCT GGCGATGCCG AGGCCAACGG AGAGGATACT CCAGAGAGAA ACTCAGAGAG
0121 TTCCGTTCTG GACACAACAC TGGCGTTTGA GCCTCAGGCG AGTACACAAT CGACTCCCAT
0181 TCATGGCGCG GTTCCCACCT GGCGCCCAAA GCGGGACAAC TGCACGCCCC CGGCTATCGA
0241 GCAGTTTCCA CAGCCGCTGA TGAATAAGTG GGCGCGACAG CACGGCGGCC TTATCCTCCA
0301 CATACTGGTG GCAGTCTTCA CTTTCTTCGG GTTGGCAATA GTTTGCGATG AGTACTTTGT
0361 GGCCAGTCTG GATCGGCTTT GCGAGGAGCT AAAGCTATCG CCAGATGTTG CGGGAGCCAC
0421 GTTTATGGCT GCCGGAAGCT CGGCTCCTGA ACTGGCCACT GTGGTGATAG GAGTGTTCTT
0481 TGCTAAGGAC GACATCGGCA |
| Assemble Data |
1090R-2.IR_full 1 CTCCGCCAAAGGAGACACCAAGGACGGACAGGTCCTGCCTCTGGATGTGGGCGCTCTGGC 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1090R-2.in silico 1 CTCCGCCAAAGGAGACACCAAGGACGGACAGGTCCTGCCTCTGGATGTGGGCGCTCTGGC 60
1090R-2.IR_full 61 CGAGGACGCTGGCGATGCCGAGGCCAACGGAGAGGATACTCCAGAGAGAAACTCAGAGAG 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1090R-2.in silico 61 CGAGGACGCTGGCGATGCCGAGGCCAACGGAGAGGATACTCCAGAGAGAAACTCAGAGAG 120
1090R-2.IR_full 121 TTCCGTTCTGGACACAACACTGGCGTTTGAGCCTCAGGCGAGTACACAATCGACTCCCAT 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1090R-2.in silico 121 TTCCGTTCTGGACACAACACTGGCGTTTGAGCCTCAGGCGAGTACACAATCGACTCCCAT 180
1090R-2.IR_full 181 TCATGGCGCGGTTCCCACCTGGCGCCCAAAGCGGGACAACTGCACGCCCCCGGCTATCGA 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1090R-2.in silico 181 TCATGGCGCGGTTCCCACCTGGCGCCCAAAGCGGGACAACTGCACGCCCCCGGCTATCGA 240
1090R-2.IR_full 241 GCAGTTTCCACAGCCGCTGATGAATAAGTGGGCGCGACAGCACGGCGGCCTTATCCTCCA 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1090R-2.in silico 241 GCAGTTTCCACAGCCGCTGATGAATAAGTGGGCGCGACAGCACGGCGGCCTTATCCTCCA 300
1090R-2.IR_full 301 CATACTGGTGGCAGTCTTCACTTTCTTCGGGTTGGCAATAGTTTGCGATGAGTACTTTGT 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1090R-2.in silico 301 CATACTGGTGGCAGTCTTCACTTTCTTCGGGTTGGCAATAGTTTGCGATGAGTACTTTGT 360
1090R-2.IR_full 361 GGCCAGTCTGGATCGGCTTTGCGAGGAGCTAAAGCTATCGCCAGATGTTGCGGGAGCCAC 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1090R-2.in silico 361 GGCCAGTCTGGATCGGCTTTGCGAGGAGCTAAAGCTATCGCCAGATGTTGCGGGAGCCAC 420
1090R-2.IR_full 421 GTTTATGGCTGCCGGAAGCTCGGCTCCTGAACTGGCCACTGTGGTGATAGGAGTGTTCTT 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1090R-2.in silico 421 GTTTATGGCTGCCGGAAGCTCGGCTCCTGAACTGGCCACTGTGGTGATAGGAGTGTTCTT 480
1090R-2.IR_full 481 TGCTAAGGACCACATCGGCA 500
|||||||||| |||||||||
1090R-2.in silico 481 TGCTAAGGACGACATCGGCA 500
|
| Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
| cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
| 100 |
482 |
0 |
0 |
0 |
NM_141202.2 |
CG1090-RB, transcript variant B (CG1090), mRNA |
| 96.47 |
465 |
3 |
2 |
2 |
NM_164343.1 |
CG1090-RA, transcript variant A (CG1090), mRNA |
| 0.2 |
1 |
2 |
2 |
3 |
NM_130616.2 |
CG4290-RA (CG4290), mRNA |
| 0 |
0 |
4 |
4 |
3 |
NM_140567.2 |
CG6017-RA (CG6017), mRNA |
| 0 |
0 |
3 |
6 |
10 |
NM_140588.1 |
CG13073-RB, transcript variant B (CG13073), mRNA |
| 0 |
0 |
3 |
6 |
8 |
NM_168654.1 |
CG13073-RA, transcript variant A (CG13073), mRNA |
| 0 |
0 |
3 |
2 |
2 |
NM_134761.2 |
CG10869-RA (CG10869), mRNA |
| 0 |
0 |
2 |
3 |
2 |
NM_079544.3 |
CG2505-RA (alpha-Est2), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_141673.4 |
CG31352-RA (CG31352), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_169301.2 |
CG31332-RC, transcript variant C (unc-115), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_169300.2 |
CG31332-RD, transcript variant D (unc-115), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_169303.2 |
CG31332-RB, transcript variant B (unc-115), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_169302.1 |
CG31332-RA, transcript variant A (unc-115), mRNA |
| 0 |
0 |
1 |
3 |
2 |
NM_140003.1 |
CG13312-RA (CG13312), mRNA |
| 0 |
0 |
1 |
3 |
2 |
NM_137897.2 |
CG3831-RA (CG3831), mRNA |
| 0 |
0 |
1 |
2 |
4 |
NM_144467.1 |
CG3267-RA (CG3267), mRNA |
| 0 |
0 |
1 |
2 |
2 |
NM_166976.1 |
CG32791-RA (CG32791), mRNA |
| 0 |
0 |
1 |
1 |
1 |
NM_132302.3 |
CG7055-RA (dalao), mRNA |
| 0 |
0 |
0 |
9 |
8 |
NM_001043216.1 |
CG34113-RO, transcript variant O (CG34113), mRNA |
| 0 |
0 |
0 |
7 |
7 |
NM_001015262.1 |
CG2893-PA.3 (CG2893), mRNA |
| 0 |
0 |
0 |
7 |
7 |
NM_001015263.1 |
CG2893-PD.3 (CG2893), mRNA |
| 0 |
0 |
0 |
7 |
7 |
NM_001015261.1 |
CG2893-PC.3 (CG2893), mRNA |
| 0 |
0 |
0 |
7 |
7 |
NM_001015260.1 |
CG2893-PB.3 (CG2893), mRNA |
| 0 |
0 |
0 |
6 |
2 |
NM_001015091.1 |
CG40269-PA.3 (CG40269), mRNA |
| 0 |
0 |
0 |
5 |
4 |
NM_132685.1 |
CG9940-RA, transcript variant A (CG9940), mRNA |
| 0 |
0 |
0 |
5 |
4 |
NM_167378.1 |
CG9940-RB, transcript variant B (CG9940), mRNA |
| 0 |
0 |
0 |
5 |
3 |
NM_136576.2 |
CG8252-RA (CG8252), mRNA |
| 0 |
0 |
0 |
5 |
3 |
NM_165933.1 |
CG8632-RB, transcript variant B (CG8632), mRNA |
| 0 |
0 |
0 |
5 |
3 |
NM_136962.2 |
CG8632-RA, transcript variant A (CG8632), mRNA |
| 0 |
0 |
0 |
4 |
10 |
NM_168179.1 |
CG32394-RA (CG32394), mRNA |
|
|
|
